. Identification of extracellular matrix-associated proteins preferentially expressed in lymphatic vessels. (A-B) Immunofluorescence staining of P21 ear skin using the indicated antibodies. The arrowheads indicates Efemp1 + collecting lymphatic vessels (A), and the arrows points to Efemp1  blood vessels (A and B) . (C and D) Western Blot analysis of LEC and BEC lysates using antibodies against Efemp1 (C) and Nid2 and Spock3 (D) , with -tubulin as a loading control. (E-E‴) Immunofluorescence staining of P21 ear skin using antibodies against Reelin (green; signal amplified using TSA procedure), PECAM-1 (red), and acetylated -tubulin (blue). Single-channel images are shown in E-E‴. Arrows and arrowheads indicate lymphatic and blood vessels, respectively. Open arrowheads show Reelin-positive nerves, and the asterisk indicates unspecific signal in scattered cells. (F and F) Immunofluorescence staining of P21 ear skin with secondary antibodies against Reelin used in E (green; signal amplified using TSA procedure), and antibodies against PECAM-1 (red). Nonspecific signal (green) was detected in scattered cells (asterisks). (G and H) Immunofluorescence staining of P15 (G) and P14 (H) ear skin using antibodies against Erp57 (green; G, to stain endoplasmic reticulum), Golph4 (green; H, to stain Golgi), Reelin (red), and PECAM-1 (blue). The images represent single confocal sections. Arrows indicate areas of colocalization. Bars: (A-F) 50 µm; (G and H) 31.75 µm. Figure S4 . Real-time imaging of lymphatic function in 3-wk-old control and Reln-deficient mice. Still images of three control (A) and three Reln / (B) hind limbs after ICG dye injections at three time points (excluding a 6-8-s delay before recording was started). In control but not in Reln / mice, except in one mutant mouse (top row in B), the dye reached the inguinal lymph node (asterisks). Bars, 0.5 cm. The fold change in expression of each gene in lymphatic vessels compared to veins, lymphatic vessels compared to arteries, and arteries compared to veins. A number >0 indicates up-regulation and <0 indicates down-regulation. Known lymphatic, blood vessel, and arterial and venous markers are up-or down-regulated in the expected pattern. Asterisks indicates arterial/venous genes with known expression also in the lymphatics. Bolt text indicates genes that are up-regulated in lymphatic vessels compared to arteries or veins ("Lymphatic"), in arteries or veins compared to lymphatic vessels ("Blood vessels"), or in arteries compared to veins or vice versa ("Arterial/"Venous"). Fold changes represent the mean of two independent samples. Genes associated with extracellular matrix structure, function, assembly, or degradation that are up-regulated ≥2-fold in lymphatic vessels compared to veins or arteries, and veins or arteries compared to lymphatic vessels in an Affymetrix GeneChip array. Asterisks indicate genes that are up-regulated ≥2-fold in both arteries and veins compared to lymphatic vessels. Fold changes represent the mean of two independent samples. Bold text indicates genes that are up-regulated in lymphatic vessels compared to arteries or veins (first set), in arteries compared to lymphatic vessels (second set), or in veins compared to lymphatic vessels (last set).
a Up-regulated in lymphatic vessels compared to arteries or veins.
b
Red up-regulated in arteries compared to lymphatic vessels.
c Up-regulated in veins compared to lymphatic vessels.
